SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-214720
Filing Date
2018-07-09
Accepted
2018-07-09 16:04:57
Documents
3
Group Members
ACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL BIOTECHNOLOGY INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D d914486dsc13d.htm SC 13D 112017
2 EX-99.3 d914486dex993.htm EX-99.3 7134
3 EX-99.4 d914486dex994.htm EX-99.4 7614
  Complete submission text file 0001193125-18-214720.txt   128541
Mailing Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address C/O ACCESS INDUSTRIES MANAGEMENT, LLC. 730 FIFTH AVENUE, 20TH FLOOR NEW YORK NY 10019 212 247 6400
Access Industries Holdings LLC (Filed by) CIK: 0001391297 (see all company filings)

IRS No.: 721620814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Subject) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90553 | Film No.: 18944744
SIC: 2836 Biological Products, (No Diagnostic Substances)